Remisión de la diabetes tipo 2

Instagram: ⁠@dr.gilbertogarciabernal⁠Infografías en X: ⁠@DoctorGilbertoGRecent progress of remission in type 2 diabetes (Ther Adv Endocrinol Metab, 2025)Sintetiza evidencia sobre intervenciones de estilo de vida intensivas, cirugía y farmacoterapias.Proporciona una ruta clínica para seleccionar estrategias personalizadas basadas en la reserva de función de las células beta.Type 2 diabetes remission: multidimensional pharmacological strategies and future perspectives (Front Endocrinol, 2025)Explora la "reprogramación" de células beta mediante terapia de insulina intensiva y el uso de nuevos agonistas duales y triples de receptores de incretinas. Propone un cambio de paradigma del control glucémico hacia la remisión de la enfermedad mediante estrategias combinadas de larga duración.Diabetes remission and diabetic complications of bariatric surgery vs. medical management in patients with type 2 diabetes: A meta-analysis of randomized controlled trials (Diabetes Obes Metab, 2025)Type 2 Diabetes Remission: A Systematic Review and Meta-analysis of Nonsurgical Randomized Controlled Trials (Diabetes Care, 2025)Aetiology of type 2 diabetes: an experimental medicine odyssey (Diabetologia, 2025)Prediabetes remission to reduce the global burden of type 2 diabetes (Trends Endocrinol Metab, 2025)Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study (Lancet Reg Health - Eur, 2025)Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study (Diabetologia, 2025)Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches (Lancet Diabetes Endocrinol, 2025)Type 2 diabetes remission with very low-energy ketogenic treatment: a retrospective real-world study (Obesity Medicine, 2025)Contemporary Clinical Perspectives on Targeting Remission of Type 2 Diabetes (J Clin Endocrinol Metab, 2024)5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (Lancet Diabetes Endocrinol, 2024)Type 2 Diabetes Remission: A New Mission in Diabetes Care (Diabetes Care, 2024)The effectiveness of lifestyle interventions for diabetes remission on patients with type 2 diabetes mellitus: A systematic review and meta-analysis (Worldviews Ev Based Nurs, 2023)Rekindling Hope for Remission: Current Impact of Diabetes for Our World’s Future Health and Economy (Endocrinol Metab Clin N Am, 2023)Remission with an Intervention: Is Metabolic Surgery the Ultimate Solution? (Endocrinol Metab Clin N Am, 2023)Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes PART 1 (Endocrinol Metab Clin N Am, 2023)Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes PART 2 (Endocrinol Metab Clin N Am, 2023)Physiology Reconfigured: How Does Bariatric Surgery Lead to Diabetes Remission? (Endocrinol Metab Clin N Am, 2023)Root Cause for Metabolic Syndrome and Type 2 Diabetes: Can Lifestyle and Nutrition Be the Answer for Remission (Endocrinol Metab Clin N Am, 2023)Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials for diabetes remission (Diabetologia, 2022)Consensus report: definition and interpretation of remission in type 2 diabetes (Diabetologia, 2021)Type 2 diabetes and remission: practical management guided by pathophysiology (J Intern Med, 2021)Nutritional basis of type 2 diabetes remission (BMJ, 2021)Understanding the mechanisms of reversal of type 2 diabetes (Lancet Diabetes Endocrinol, 2019)Effectiveness of lifestyle-based weight loss interventions for adults with type 2 diabetes: a systematic review and meta-analysis (Diabetes Obes Metab, 2015)